-
Gland Pharma
2,826.60 1,575.00(%) -
Tata Technolog.
830.10 890.15(%) -
IFCI
103.95 101.60(%) -
HFCL
231.40 257.00(%) -
Lumino Inds
122.00 119.00(%) -
Jindal Worldwide
57.06 47.55(%) -
Netweb Technol.
5,424.00 5,810.00(%) -
Angel One
308.20 360.20(%) -
HBL Engineering
723.85 1,121.95(%) -
Multi Comm. Exc.
3,257.00 3,479.80(%) -
Adani Total Gas
620.85 859.70(%) -
Lenskart Solut.
694.75 680.95(%) -
Oberoi Realty
1,932.25 1,985.00(%) -
RBL Bank
413.50 410.45(%) -
Tejas Networks
613.50 644.75(%) -
Polycab India
8,308.55 6,660.50(%) -
Antelopus Selan
986.05 357.00(%) -
Nuvoco Vistas
353.50 477.35(%) -
One 97
1,691.50 1,732.00(%) -
Reliance Industries
1,332.30 1,611.20(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Mardia Samyoung Capillary Tubes Company Ltd Trading
- Mardia Rasiklal
- BSE Code : 3603.0
- ISIN : INE277E01026
-
Today’s Low
49.50 -
Today’s High
52.58
-
Open
51.28 -
Perv Close
51.03 -
52W Low
38.50 -
52W High
123.40
Key Indicators
-
P/E(TTM)
115.91
-
Mar.Cap (₹Cr.)
405.25
-
Div & Yield %
0.00
-
Book Value(₹)
13.27
-
Debt-Equity Ratio
-0.06
-
AGM Date
03-Sep-2026
-
EPS
0.44
-
P/E Ratio
115.91
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
405.25
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
79.46
-
BV (₹)
13.30
-
Sales( ₹ in Cr.)
73.87
-
NP (in Cr.)
2.23
-
NP Var(%)
81.0
-
Div%
0.0
-
CPS (₹)
0.30
-
EPS (₹)
0.30
-
Traded Value (₹ in Lakhs)
405.25
-
52 Week High
123.40
-
52 Week Low
38.50
-
Price BSE
51.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
405.25
-
P/C Ratio
182.00
-
P/E Ratio
182.10
-
Price Vs.BV
0.30
-
27-Aug-2026( 04:44)
Corporate News - Mardi... - <p>Mardia Samyoung Capillary T...
-
04-Aug-2026( 02:16)
Corporate News - Mardi... - Mardia Samyoung Capillary Tube...
-
13-May-2026( 07:26)
Results - Announcements - Mardi... - Net profit of Mardia Samyoung...
-
08-May-2026( 11:01)
Corporate News - Mardi... - Mardia Samyoung Capillary Tube...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.76 | 0.09 | 0.28 | 0.46 | 0.25 | 0.09 |
| Stock Adjustments | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Total Income | 2.76 | 0.09 | 0.28 | 0.45 | 0.25 | 0.09 |
| EXPENDITURE : | ||||||
| Raw Materials | 0.00 | 0.00 | 0.07 | 0.01 | 0.00 | 0.00 |
| Power and Fuel Cost | 0.02 | 0.11 | 0.02 | 0.02 | 0.02 | 0.01 |
| Employee Cost | 0.07 | 0.16 | 0.15 | 0.13 | 0.12 | 0.13 |
| Other Manufacturing Expenses | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.03 |
| Selling and Administration Expenses | 0.70 | 0.31 | 0.18 | 0.19 | 0.10 | 0.13 |
| Miscellaneous Expenses | 0.78 | 0.00 | 0.00 | 0.01 | 0.00 | 0.02 |
| Employee Benefit Expenses | 0.07 | 0.16 | 0.15 | 0.13 | 0.12 | 0.13 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1.56 | 0.57 | 0.42 | 0.39 | 0.25 | 0.33 |
| Operating Profit | 1.20 | -0.48 | -0.15 | 0.06 | 0.00 | -0.24 |
| Interest | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.20 | -0.48 | -0.20 | 0.06 | 0.00 | -0.24 |
| Depreciation | 0.00 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Profit Before Tax | 1.20 | -0.51 | -0.23 | 0.03 | -0.03 | -0.27 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | 1.20 | -0.51 | -0.23 | 0.03 | -0.03 | -0.27 |
| Extraordinary Items | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | 1.23 | -0.51 | -0.23 | 0.03 | -0.03 | -0.27 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | -20.17 | -19.66 | -19.44 | -19.47 | -19.44 | -19.17 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -18.97 | -20.17 | -19.66 | -19.44 | -19.47 | -19.44 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 1.72 | -0.73 | -0.33 | 0.05 | -0.04 | -0.39 |
| Earnings Per Share(Adj)-Unit Curr | 1.72 | - | - | - | -0.04 | - |
| Book Value | 1.95 | 0.22 | 0.95 | 1.28 | 1.23 | 1.27 |
| Book Value(Adj)-Unit Curr | 1.95 | - | - | - | 1.23 | - |
